Field Trip Health To Divide Into Two Separate Firms
Field Trip Health (TSX: FTRP) is set to be split into two separate firms. The company last night indicated that
Read more
Psychedelics
Mydecine Announces 50 To 1 Share Consolidation
Mydecine Innovations (NEO: MYCO) is the latest firm to announce a reverse stock split amid a recent trend amongst small
Read more
Numinus Wellness To Acquire Novamind In All Stock Transaction At $0.44 Per Share
Consolidation within the psychedelics space is getting underway, with the announcement this morning that Numinus Wellness (TSX: NUMI) will be
Read more
Red Light Holland Acquires 100 Acres Of Land To Grow Mushrooms
Evidently there is big money within the mushroom market. Red Light Holland (CSE: TRIP) this morning indicated it is dropping
Read more
Mind Medicine CFO Quits Ahead Of Release Of 2021 Financial Results
It’s always a positive sign when a chief financial officer resigns the last business day before annual filings are to
Read more
Core One Labs Looks To Sell Out To Big Pharma As Capital Dries Up In Psychedelics Space
Evidently there has been a shift of strategy behind the scenes at Core One Labs (CSE: COOL). The company late
Read more
Mind Cure Gives Up On Psychedelics, Fires C-Suite, And Reverts To Shell After Strategic Review
In a sign of what’s to come for most psychedelic-related names, Mind Cure Health (CSE: MCUR) this morning effectively announced
Read more
Bright Minds Moves Into Clinical Development Stage Following Positive Toxicity Results
Drug development continues for the Bright Minds Biosciences (CSE: DRUG) lead product. The firm this morning published positive results from
Read more
Mind Medicine Sees Final Co-Founder Leave The Company
Mind Medicine (NEO: MMED) appears to now be fully under new management. On Friday evening, after the close of markets,
Read more
MindMed Concludes Phase 1 Clinical Trial Of Psychedelic Derivative Drug For Opioid Use Disorder
Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, has recently concluded the phase 1 clinical trial for its
Read more